Ballentine Partners LLC Invests $223,000 in Cooper Companies, Inc. (The) (COO)

Ballentine Partners LLC acquired a new position in shares of Cooper Companies, Inc. (The) (NYSE:COO) in the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 941 shares of the medical device company’s stock, valued at approximately $223,000.

A number of other institutional investors have also added to or reduced their stakes in COO. Teachers Advisors LLC lifted its holdings in Cooper Companies, Inc. (The) by 17.8% during the 1st quarter. Teachers Advisors LLC now owns 71,906 shares of the medical device company’s stock worth $14,373,000 after buying an additional 10,874 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in Cooper Companies, Inc. (The) by 4.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 184,266 shares of the medical device company’s stock worth $36,831,000 after buying an additional 8,192 shares in the last quarter. Morgan Stanley lifted its holdings in Cooper Companies, Inc. (The) by 27.9% during the 1st quarter. Morgan Stanley now owns 51,070 shares of the medical device company’s stock worth $10,208,000 after buying an additional 11,129 shares in the last quarter. Bank of Montreal Can lifted its holdings in Cooper Companies, Inc. (The) by 49.0% during the 2nd quarter. Bank of Montreal Can now owns 48,995 shares of the medical device company’s stock worth $11,731,000 after buying an additional 16,110 shares in the last quarter. Finally, Gateway Investment Advisers LLC lifted its holdings in Cooper Companies, Inc. (The) by 5.7% during the 2nd quarter. Gateway Investment Advisers LLC now owns 3,691 shares of the medical device company’s stock worth $884,000 after buying an additional 200 shares in the last quarter. Institutional investors own 96.71% of the company’s stock.

COO has been the topic of a number of research reports. Zacks Investment Research lowered shares of Cooper Companies, Inc. (The) from a “buy” rating to a “hold” rating in a report on Monday, August 28th. Robert W. Baird reiterated a “buy” rating and set a $267.00 target price (up from $251.00) on shares of Cooper Companies, Inc. (The) in a report on Sunday, September 3rd. KeyCorp reiterated a “hold” rating on shares of Cooper Companies, Inc. (The) in a report on Monday, August 28th. Piper Jaffray Companies increased their target price on shares of Cooper Companies, Inc. (The) from $265.00 to $280.00 and gave the stock an “overweight” rating in a report on Friday, September 1st. Finally, Jefferies Group LLC restated a “buy” rating and issued a $250.00 price objective on shares of Cooper Companies, Inc. (The) in a report on Tuesday, September 12th. Seven analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $261.11.

In other Cooper Companies, Inc. (The) news, Director Gary S. Petersmeyer sold 3,977 shares of the firm’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $244.94, for a total transaction of $974,126.38. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 1.60% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was reported by Markets Daily and is the sole property of of Markets Daily. If you are viewing this story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.themarketsdaily.com/2017/11/13/ballentine-partners-llc-invests-223000-in-cooper-companies-inc-the-coo.html.

Cooper Companies, Inc. (COO) traded down $2.89 during midday trading on Monday, hitting $229.06. 341,800 shares of the company were exchanged, compared to its average volume of 428,798. Cooper Companies, Inc. has a 1 year low of $158.73 and a 1 year high of $256.39. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.51 and a quick ratio of 1.29. The stock has a market cap of $11,212.31, a P/E ratio of 24.50, a price-to-earnings-growth ratio of 1.97 and a beta of 0.55.

Cooper Companies, Inc. (The) (NYSE:COO) last issued its quarterly earnings data on Thursday, August 31st. The medical device company reported $2.64 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.58 by $0.06. Cooper Companies, Inc. (The) had a net margin of 16.45% and a return on equity of 16.00%. The company had revenue of $556.00 million for the quarter, compared to the consensus estimate of $552.32 million. During the same period last year, the firm posted $2.30 EPS. Cooper Companies, Inc. (The)’s revenue for the quarter was up 8.0% on a year-over-year basis. equities analysts expect that Cooper Companies, Inc. will post 9.72 earnings per share for the current year.

Cooper Companies, Inc. (The) Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies, Inc. (The) (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply